GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Other Current Payables

Embecta (FRA:JX7) Other Current Payables : €35 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Other Current Payables?

Embecta's Other Current Payables for the quarter that ended in Mar. 2024 was €35 Mil.

Embecta's quarterly Other Current Payables declined from Sep. 2023 (€68 Mil) to Dec. 2023 (€53 Mil) and declined from Dec. 2023 (€53 Mil) to Mar. 2024 (€35 Mil).

Embecta's annual Other Current Payables increased from Sep. 2021 (€0 Mil) to Sep. 2022 (€67 Mil) and increased from Sep. 2022 (€67 Mil) to Sep. 2023 (€68 Mil).


Embecta Other Current Payables Historical Data

The historical data trend for Embecta's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Other Current Payables Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Other Current Payables
- - - 67.17 68.49

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.40 63.32 68.49 52.82 35.42

Embecta Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Embecta Other Current Payables Related Terms

Thank you for viewing the detailed overview of Embecta's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (FRA:JX7) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines